Find L-Arginine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: L-arginine, 74-79-3, L-(+)-arginine, L(+)-arginine, L-arg, (s)-2-amino-5-guanidinopentanoic acid
Molecular Formula
C6H14N4O2
Molecular Weight
174.20  g/mol
InChI Key
ODKSFYDXXFIFQN-BYPYZUCNSA-N
FDA UNII
94ZLA3W45F

L-Arginine
An essential amino acid that is physiologically active in the L-form.
1 2D Structure

L-Arginine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid
2.1.2 InChI
InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1
2.1.3 InChI Key
ODKSFYDXXFIFQN-BYPYZUCNSA-N
2.1.4 Canonical SMILES
C(CC(C(=O)O)N)CN=C(N)N
2.1.5 Isomeric SMILES
C(C[C@@H](C(=O)O)N)CN=C(N)N
2.2 Other Identifiers
2.2.1 UNII
94ZLA3W45F
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Arginine Hydrochloride

2. Arginine, L Isomer

3. Arginine, L-isomer

4. Dl Arginine Acetate, Monohydrate

5. Dl-arginine Acetate, Monohydrate

6. Hydrochloride, Arginine

7. L Arginine

8. L-arginine

9. L-isomer Arginine

10. Monohydrate Dl-arginine Acetate

2.3.2 Depositor-Supplied Synonyms

1. L-arginine

2. 74-79-3

3. L-(+)-arginine

4. L(+)-arginine

5. L-arg

6. (s)-2-amino-5-guanidinopentanoic Acid

7. H-arg-oh

8. (l)-arginine

9. Arginina

10. Arginine, L-

11. Arginine (van)

12. L-arginin

13. Argininum [inn-latin]

14. Arginina [inn-spanish]

15. L-ornithine, N5-(aminoiminomethyl)-

16. Argamine

17. Argivene

18. Detoxargin

19. Levargin

20. L-alpha-amino-delta-guanidinovaleric Acid

21. Arg

22. Minophagen A

23. 1-amino-4-guanidovaleric Acid

24. Ccris 3609

25. (s)-(+)-arginine

26. Nsc 206269

27. Chebi:16467

28. Hsdb 1429

29. Ai3-24165

30. (s)-2-amino-5-((aminoiminomethyl)amino)pentanoic Acid

31. (s)-2-amino-5-guanidinovaleric Acid

32. Brn 1725413

33. L-norvaline, 5-((aminoiminomethyl)amino)-

34. 2-amino-5-guanidinovaleric Acid

35. Chembl1485

36. (2s)-2-amino-5-guanidinopentanoic Acid

37. (s)-2-amino-5-[(aminoiminomethyl)amino]pentanoic Acid

38. (2s)-2-amino-5-(diaminomethylideneamino)pentanoic Acid

39. 94zla3w45f

40. Pentanoic Acid, 2-amino-5-((aminoiminomethyl)amino)-, (s)-

41. (2s)-2-amino-5-(carbamimidamido)pentanoic Acid

42. L-arginine, Monohydrochloride

43. Nsc-206269

44. Arginine (l-arginine)

45. R-gene

46. L-norvaline, 5-[(aminoiminomethyl)amino]-

47. (2s)-2-amino-5-carbamimidamidopentanoic Acid

48. Dsstox_cid_21056

49. Dsstox_rid_79618

50. Dsstox_gsid_41056

51. Argininum

52. Pentanoic Acid, 2-amino-5-[(aminoiminomethyl)amino]-, (s)-

53. Arginine [usan:inn]

54. Cas-74-79-3

55. Arginine [usp:inn]

56. Einecs 200-811-1

57. Mfcd00002635

58. 2-amino-5-guanidino-pentanoic Acid

59. Unii-94zla3w45f

60. Nsc203450

61. 3h-l-arginine

62. L-arginine, Labeled With Tritium

63. 1laf

64. L-a-amino-d-guanidinovaleric Acid

65. Ncgc00015064-02

66. (s)-arginine

67. L(+) Arginine

68. L-aryginine,(s)

69. H-arg

70. L-(+) Arginine

71. L(+)-arginine;

72. L-arginine (9ci)

73. Arginine (usp/inn)

74. Tocris-0663

75. (2s)-2-amino-5-guanidino-pentanoic Acid

76. Arginine [hsdb]

77. Arginine [inci]

78. L-arginine (jp17)

79. Arginine [inn]

80. Arginine [ii]

81. Arginine [mi]

82. Arginine [vandf]

83. Gnd

84. Lopac-a-5006

85. Arginine, L- (8ci)

86. Arginine [mart.]

87. L-arginine [fcc]

88. L-arginine [jan]

89. Arginine [who-dd]

90. Bmse000029

91. Bmse000899

92. Bmse000919

93. Epitope Id:140084

94. L-arginine (h-arg-oh)

95. L-arginine [fhfi]

96. Ec 200-811-1

97. Schembl1791

98. 2-amino-5-guanidinovalerate

99. Lopac0_000077

100. Arginine Hydrochloride(usan)

101. Gtpl721

102. L-arginine [usp-rs]

103. 4-04-00-02648 (beilstein Handbook Reference)

104. L-a-amino-d-guanidinovalerate

105. L-amino-4-guanidovaleric Acid

106. Arginine [ep Impurity]

107. Us9138393, L-arginine

108. Us9144538, L-arginine

109. 1-amino-4-guanidovalerlic Acid

110. Arginine [ep Monograph]

111. Arginine [usp Monograph]

112. Dtxsid6041056

113. Bdbm21959

114. L-arginine, 99%, Fcc, Fg

115. Bdbm181132

116. Hms3260o15

117. N5-(aminoiminomethyl)-l-ornithine

118. Hy-n0455

119. Zinc1532525

120. L-arginine, Vetec(tm), 98.5%

121. Tox21_113046

122. Tox21_500077

123. Ac-083

124. L-2-amino-5-guanidinopentanoic Acid

125. L-alpha-amino-delta-guanidinovalerate

126. L-arginine, Reagent Grade, >=98%

127. S5634

128. Akos006239069

129. Akos015854096

130. Tox21_113046_1

131. Am81500

132. Ccg-204172

133. Db00125

134. Lp00077

135. Sdccgsbi-0050065.p002

136. L-arginine, 99%, Natural, Fcc, Fg

137. (s)-2-amino-5-guanidino-pentanoic Acid

138. 5-[(aminoiminomethyl)amino]-l-norvaline

139. Ncgc00015064-01

140. Ncgc00024715-01

141. Ncgc00024715-02

142. Ncgc00024715-03

143. Ncgc00024715-04

144. Ncgc00024715-05

145. Ncgc00024715-10

146. Ncgc00260762-01

147. 4455-52-1

148. As-14190

149. L-arginine, Bioultra, >=99.5% (nt)

150. Sbi-0207062.p001

151. A0526

152. A7079

153. Eu-0100077

154. L-arginine, Saj Special Grade, >=98.0%

155. A 5006

156. C00062

157. D02982

158. L-arginine, Vetec(tm) Reagent Grade, >=98%

159. Lysine Acetate Impurity F [ep Impurity]

160. M02981

161. 2-azaniumyl-5-(diaminomethyleneammonio)pentanoate

162. Ab00374192_03

163. Norvaline, 5-[(aminoiminomethyl)amino]-, (l)-

164. 002a635

165. A837397

166. A929348

167. Q173670

168. Sr-01000075479

169. Sr-01000597671

170. (s)-2-amino-5-[(aminoiminomethyl)amino]-pentanoate

171. (s)-2-amino-5-[(aminoiminomethyl)amino]pentanoate

172. Sr-01000075479-1

173. Sr-01000597671-1

174. W-104410

175. (s)-2-amino-5-[(aminoiminomethyl)amino]-pentanoic Acid

176. Arginine, European Pharmacopoeia (ep) Reference Standard

177. (2s)-2-amino-5-[(diaminomethylidene)amino]pentanoic Acid

178. 7f15b0c7-356d-45d7-ac33-03aee4394a0e

179. S-(+)-2-amino-5-[(aminoiminomethyl)amino]pentanoic Acid

180. (2s)-2-azanyl-5-[bis(azanyl)methylideneamino]pentanoic Acid

181. L-arginine, United States Pharmacopeia (usp) Reference Standard

182. L-arginine, Pharmaceutical Secondary Standard; Certified Reference Material

183. L-

184. L-arginine, From Non-animal Source, Meets Ep, Usp Testing Specifications, Suitable For Cell Culture, 98.5-101.0%

185. L-arginine, Pharmagrade, Ajinomoto, Ep, Usp, Manufactured Under Appropriate Gmp Controls For Pharma Or Biopharmaceutical Production, Suitable For Cell Culture

2.3.3 Other Synonyms

1. L-arginine

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 174.20 g/mol
Molecular Formula C6H14N4O2
XLogP3-4.2
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count4
Rotatable Bond Count5
Exact Mass174.11167570 g/mol
Monoisotopic Mass174.11167570 g/mol
Topological Polar Surface Area128 Ų
Heavy Atom Count12
Formal Charge0
Complexity176
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameR-gene 10
Active IngredientArginine hydrochloride
Dosage FormInjectable
RouteInjection
Strength10gm/100ml
Market StatusPrescription
CompanyPharmacia And Upjohn

2 of 2  
Drug NameR-gene 10
Active IngredientArginine hydrochloride
Dosage FormInjectable
RouteInjection
Strength10gm/100ml
Market StatusPrescription
CompanyPharmacia And Upjohn

4.2 Therapeutic Uses

EXPTL USE: IN MICE, L-ARGININE-HCL HAD AN INHIBITORY EFFECT ON MURINE SARCOMA VIRUS-MOLONEY & C3H BREAST ADENOCARCINOMA TUMOR SYSTEMS.

CRITSELIS AN ET AL; L-ARGININE INCREASES RESISTANCE TO TUMORS; CURR CHEMOTHER PROC INT CONGR CHEMOTHER, 10TH, VOL 2, 1978, 1122-4


EXPTL USE: EXPTL DIETS GIVEN 10 DAYS AFTER WALKER 256 CARCINOSARCOMA CELLS INOCULATED INTO RATS, RESULTED IN LOWER TUMOR WEIGHTS.

TAKAMURA C; INHIBITORY EFFECT OF ARGININE-SUPPLEMENTED DIETS ON GROWTH OF WALKER 256 CARCINOSARCOMA; KANSAI IKA DAIGAKU ZASSHI 29(3) 519 (1977)


EXPTL USE: L-ARGININE-HCL INCR IN VITRO MOTILITY IN SPECIMENS OF HUMAN SEMEN EXHIBITING SUBNORMAL MOTILITY. EFFECT WAS DOSE DEPENDENT.

KELLER DW ET AL; L-ARGININE STIMULATION OF HUMAN SPERM MOTILITY IN VITRO; BIOL REPROD 13(2) 154 (1975)


EXPTL USE: ARGININE (1% IN DIET) GIVEN TO RATS INCR THYMIC SIZE & PREVENTED THYMIC INVOLUTION WHICH OCCURS WITH INJURY. ARGININE PROMOTED WOUND HEALING IN RATS.

BARBUL A ET AL; ARGININE: A THYMOTROPIC & WOUND-HEALING PROMOTING AGENT; SURG FORUM 28: 101 (1977)


For more Therapeutic Uses (Complete) data for (L)-ARGININE (6 total), please visit the HSDB record page.


4.3 Drug Indication

Used for nutritional supplementation, also for treating dietary shortage or imbalance.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Studies have shown that is has improved immune responses to bacteria, viruses and tumor cells; promotes wound healing and regeneration of the liver; causes the release of growth hormones; considered crucial for optimal muscle growth and tissue repair.


5.2 Absorption, Distribution and Excretion

Absorption

Absorbed from the lumen of the small intestine into the enterocytes. Absorption is efficient and occurs by an active transport mechanism.


5.3 Metabolism/Metabolites

Some metabolism of L-arginine takes place in the enterocytes. L-arginine not metabolized in the enterocytes enters the portal circulation from whence it is transported to the liver, where again some portion of the amino acid is metabolized.


PRODUCT OF OXIDATIVE DEAMINATION OR TRANSAMINATION OF L-ARGININE IS ALPHA-KETO-GAMMA-GUANIDOVALERIC ACID; PRODUCT OF DECARBOXYLATION IS AGMATINE. PATHWAYS & PRODUCTS OF METABOLISM: ARGININE YIELDS ORNITHINE + UREA; ARGININE YIELDS CITRULLINE + NH3; ARGININE + GLYCINE YIELDS GUANIDOACETIC ACID + ORNITHINE /FROM TABLE/

Fenaroli's Handbook of Flavor Ingredients. Volume 2. Edited, translated, and revised by T.E. Furia and N. Bellanca. 2nd ed. Cleveland: The Chemical Rubber Co., 1975., p. 829


5.4 Mechanism of Action

Many of supplemental L-arginine's activities, including its possible anti-atherogenic actions, may be accounted for by its role as the precursor to nitric oxide or NO. NO is produced by all tissues of the body and plays very important roles in the cardiovascular system, immune system and nervous system. NO is formed from L-arginine via the enzyme nitric oxide synthase or synthetase (NOS), and the effects of NO are mainly mediated by 3,'5' -cyclic guanylate or cyclic GMP. NO activates the enzyme guanylate cyclase, which catalyzes the synthesis of cyclic GMP from guanosine triphosphate or GTP. Cyclic GMP is converted to guanylic acid via the enzyme cyclic GMP phosphodiesterase. NOS is a heme-containing enzyme with some sequences similar to cytochrome P-450 reductase. Several isoforms of NOS exist, two of which are constitutive and one of which is inducible by immunological stimuli. The constitutive NOS found in the vascular endothelium is designated eNOS and that present in the brain, spinal cord and peripheral nervous system is designated nNOS. The form of NOS induced by immunological or inflammatory stimuli is known as iNOS. iNOS may be expressed constitutively in select tissues such as lung epithelium. All the nitric oxide synthases use NADPH (reduced nicotinamide adenine dinucleotide phosphate) and oxygen (O2) as cosubstrates, as well as the cofactors FAD (flavin adenine dinucleotide), FMN (flavin mononucleotide), tetrahydrobiopterin and heme. Interestingly, ascorbic acid appears to enhance NOS activity by increasing intracellular tetrahydrobiopterin. eNOS and nNOS synthesize NO in response to an increased concentration of calcium ions or in some cases in response to calcium-independent stimuli, such as shear stress. In vitro studies of NOS indicate that the Km of the enzyme for L-arginine is in the micromolar range. The concentration of L-arginine in endothelial cells, as well as in other cells, and in plasma is in the millimolar range. What this means is that, under physiological conditions, NOS is saturated with its L-arginine substrate. In other words, L-arginine would not be expected to be rate-limiting for the enzyme, and it would not appear that supraphysiological levels of L-arginine which could occur with oral supplementation of the amino acid^would make any difference with regard to NO production. The reaction would appear to have reached its maximum level. However, in vivo studies have demonstrated that, under certain conditions, e.g. hypercholesterolemia, supplemental L-arginine could enhance endothelial-dependent vasodilation and NO production.


USDMF

read-more
read-moreread-more

01

Acs Dobfar Spa

Italy

USDMF

arrow
CAMX
Not Confirmed

01

02

Ajinomoto Co Inc

Japan

USDMF

arrow
CAMX
Not Confirmed

02

CAMX
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2021-08-04

Pay. Date : 2020-11-30

DMF Number : 31646

Submission : 2017-04-20

Status : Active

Type : II

blank

03

CAMX
Not Confirmed

04

CAMX
Not Confirmed

05

Latina Pharma Spa

Germany

USDMF

arrow
CAMX
Not Confirmed

05

CAMX
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-09-04

Pay. Date : 2014-05-23

DMF Number : 28191

Submission : 2014-05-15

Status : Active

Type : II

blank

06

Corden Pharma Latina Spa

Germany

USDMF

arrow
CAMX
Not Confirmed

06

CAMX
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 10131

Submission : 1989-04-07

Status : Inactive

Type : II

blank

07

Tanabe Seiyaku Co Ltd

Japan

USDMF

arrow
CAMX
Not Confirmed

07

08

Orchid Pharma Ltd

India

USDMF

arrow
CAMX
Not Confirmed

09

Orchid Pharma Ltd

India

USDMF

arrow
CAMX
Not Confirmed

09

CAMX
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2021-08-09

Pay. Date : 2021-08-04

DMF Number : 18923

Submission : 2005-10-31

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Emifarma will be responsible for initial development & testing of the Company’s Mango ED products a combination of Tadalafil, Oxytocin, and L-Arginine intended for Mexican and Latin American markets.


Lead Product(s): Tadalafil,L-Arginine,Oxytocin

Therapeutic Area: Psychiatry/Psychology Brand Name: Mango ED

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Mangoceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement December 04, 2024

blank

01

Emifarma

Mexico
arrow
CAMX
Not Confirmed

Emifarma

Mexico
arrow
CAMX
Not Confirmed

Details : Emifarma will be responsible for initial development & testing of the Company’s Mango ED products a combination of Tadalafil, Oxytocin, and L-Arginine intended for Mexican and Latin American markets.

Product Name : Mango ED

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

December 04, 2024

blank
  • Development Update

Details:

Undisclosed


Lead Product(s): L-Arginine,Inapplicable

Therapeutic Area: Dental and Oral Health Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Colgate Palmolive

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 15, 2024

blank

02

Tufts University

Country
arrow
CAMX
Not Confirmed

Tufts University

Country
arrow
CAMX
Not Confirmed

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

April 15, 2024

blank

03

CAMX
Not Confirmed
CAMX
Not Confirmed

Details : Undisclosed

Product Name : Undisclosed

Product Type : Vitamins/Minerals/Inorganic Salts

Upfront Cash : Inapplicable

December 26, 2023

blank

Details:

The Company intends to use the net proceeds to finance the marketing and operational expenses associated with the planned marketing of its Mango ED, a combination of Tadalafil, Oxytocin, and L-Arginine that have been traditionally used to treat sexual dysfunction.


Lead Product(s): Tadalafil,L-Arginine,Oxytocin

Therapeutic Area: Psychiatry/Psychology Brand Name: Tadalafil Mango

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Boustead Securities

Deal Size: $1.2 million Upfront Cash: Undisclosed

Deal Type: Public Offering December 15, 2023

blank

04

CAMX
Not Confirmed
CAMX
Not Confirmed

Details : The Company intends to use the net proceeds to finance the marketing and operational expenses associated with the planned marketing of its Mango ED, a combination of Tadalafil, Oxytocin, and L-Arginine that have been traditionally used to treat sexual dy...

Product Name : Tadalafil Mango

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

December 15, 2023

blank
  • Development Update

Details:

Undisclosed


Lead Product(s): L-Arginine,Ascorbic Acid

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Vitamins/Minerals/Inorganic Salts

Sponsor: DAMOR Farmaceutici S.p.a.

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 21, 2023

blank

05

Fondazione IRCCS Ca' Granda

Country
arrow
CAMX
Not Confirmed

Fondazione IRCCS Ca' Granda

Country
arrow
CAMX
Not Confirmed

Details : Undisclosed

Product Name : Undisclosed

Product Type : Vitamins/Minerals/Inorganic Salts

Upfront Cash : Inapplicable

September 21, 2023

blank

Details:

The partnership aims bring its flagship product, Mango, a combination of Tadalafil, Oxytocin, and L-Arginine that have been traditionally used to treat sexual dysfunction, to New York.


Lead Product(s): Tadalafil,L-Arginine,Oxytocin

Therapeutic Area: Psychiatry/Psychology Brand Name: Tadalafil Mango

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Greater NY Chamber of Commerce

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership September 08, 2023

blank

06

CAMX
Not Confirmed
CAMX
Not Confirmed

Details : The partnership aims bring its flagship product, Mango, a combination of Tadalafil, Oxytocin, and L-Arginine that have been traditionally used to treat sexual dysfunction, to New York.

Product Name : Tadalafil Mango

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

September 08, 2023

blank

Details:

Mango (sildenafil citrate) mango-flavored, rapid dissolve tablet is a Phosphodiesterase-5 inhibitor, which is being indicated for the treatment of erectile dysfunction.


Lead Product(s): Sildenafil Citrate,L-Arginine,Oxytocin

Therapeutic Area: Psychiatry/Psychology Brand Name: Mango

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 16, 2023

blank

07

CAMX
Not Confirmed
CAMX
Not Confirmed

Details : Mango (sildenafil citrate) mango-flavored, rapid dissolve tablet is a Phosphodiesterase-5 inhibitor, which is being indicated for the treatment of erectile dysfunction.

Product Name : Mango

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

August 16, 2023

blank

Details:

ITM-11 consists of two components: the medical radioisotope non-carrier-added lutetium-177 (n.c.a. 177Lu) and the targeting molecule edotreotide, a synthetic form of the peptide hormone somatostatin that targets neuroendocrine tumor-specific receptors.


Lead Product(s): 177-Lu Edotreotide,L-Arginine,Lysine

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Radiolabeled Compounds

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 27, 2022

blank

08

CAMX
Not Confirmed
CAMX
Not Confirmed

Lead Product(s) : 177-Lu Edotreotide,L-Arginine,Lysine

Therapeutic Area : Oncology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : ITM-11 consists of two components: the medical radioisotope non-carrier-added lutetium-177 (n.c.a. 177Lu) and the targeting molecule edotreotide, a synthetic form of the peptide hormone somatostatin that targets neuroendocrine tumor-specific receptors.

Product Name : Undisclosed

Product Type : Radiolabeled Compounds

Upfront Cash : Inapplicable

October 27, 2022

blank

Details:

Undisclosed


Lead Product(s): L-Arginine,Inapplicable

Therapeutic Area: Dental and Oral Health Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 30, 2022

blank

09

CAMX
Not Confirmed
CAMX
Not Confirmed

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

September 30, 2022

blank

Details:

ITM-11, a targeted radionuclide therapy consisting of high-quality radioisotope, no-carrier-added lutetium-177 combined with somatostatin analog edotreotide is best standard of care for patients with neuroendocrine tumors.


Lead Product(s): 177-Lu Edotreotide,L-Arginine,Lysine

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Radiolabeled Compounds

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 03, 2022

blank

10

CAMX
Not Confirmed
CAMX
Not Confirmed

Lead Product(s) : 177-Lu Edotreotide,L-Arginine,Lysine

Therapeutic Area : Oncology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : ITM-11, a targeted radionuclide therapy consisting of high-quality radioisotope, no-carrier-added lutetium-177 combined with somatostatin analog edotreotide is best standard of care for patients with neuroendocrine tumors.

Product Name : Undisclosed

Product Type : Radiolabeled Compounds

Upfront Cash : Inapplicable

September 03, 2022

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Adcock Ingram

South Africa
CAMX
Not Confirmed
arrow

Adcock Ingram

South Africa
arrow
CAMX
Not Confirmed

L-arginine

Brand Name : Oliclinomel N7-1000 E

Dosage Form : INF

Dosage Strength : 10%/bag

Packaging : 2000X1%/bag

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

02

CAMX
Not Confirmed
arrow
arrow
CAMX
Not Confirmed

Arginine

Brand Name : Nutriflex Omega Specialized

Dosage Form : INF

Dosage Strength : 3.78g/1000ml

Packaging : 625X1g/1000ml

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank

03

CAMX
Not Confirmed
arrow
arrow
CAMX
Not Confirmed

L-arginine

Brand Name : Nutriflex Lipid Peri

Dosage Form : INF

Dosage Strength : 2.16g/1000ml

Packaging : 2500X1g/1000ml

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank

04

CAMX
Not Confirmed
arrow
arrow
CAMX
Not Confirmed

L-arginine

Brand Name : Nutriflex Lipid Special Without Electrolytes

Dosage Form : INF

Dosage Strength : 3.779g/1000ml

Packaging : 2500X1g/1000ml

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank

05

CAMX
Not Confirmed
arrow
arrow
CAMX
Not Confirmed

ARGININE

Brand Name : TRAVASOL

Dosage Form : SOLUTION

Dosage Strength : 1.15G/100ML

Packaging : 3000

Approval Date :

Application Number : 872296

Regulatory Info :

Registration Country : Canada

blank

06

CAMX
Not Confirmed
arrow
arrow
CAMX
Not Confirmed

L-ARGININE

Brand Name : CLINIMIX

Dosage Form : LIQUID

Dosage Strength : 520MG/100ML

Packaging : 1000ML

Approval Date :

Application Number : 2046709

Regulatory Info :

Registration Country : Canada

blank

07

CAMX
Not Confirmed
arrow
arrow
CAMX
Not Confirmed

L-ARGININE

Brand Name : PERIOLIMEL 2.5% E

Dosage Form : EMULSION

Dosage Strength : 2.48G/L

Packaging : 1000/1500/2000/2500ML

Approval Date :

Application Number : 2352494

Regulatory Info :

Registration Country : Canada

blank

08

CAMX
Not Confirmed
arrow
arrow
CAMX
Not Confirmed

L-ARGININE

Brand Name : CLINIMIX

Dosage Form : SOLUTION

Dosage Strength : 690MG/100ML

Packaging :

Approval Date :

Application Number : 2498448

Regulatory Info :

Registration Country : Canada

blank

09

Darnytsia

Ukraine
CAMX
Not Confirmed
arrow

Darnytsia

Ukraine
arrow
CAMX
Not Confirmed

L-Arginine

Brand Name : Argitec

Dosage Form : Solution For Infusion

Dosage Strength : 8MG/1ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Ukraine

blank

10

CAMX
Not Confirmed
arrow
arrow
CAMX
Not Confirmed

ARGININE

Brand Name : ESSEPNA

Dosage Form : SOLUTION

Dosage Strength : 1.2G/100ML

Packaging :

Approval Date :

Application Number : 2510324

Regulatory Info :

Registration Country : Canada

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 74-79-3 / L-Arginine API manufacturers, exporters & distributors?

L-Arginine manufacturers, exporters & distributors 1

11

PharmaCompass offers a list of L-Arginine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right L-Arginine manufacturer or L-Arginine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred L-Arginine manufacturer or L-Arginine supplier.

PharmaCompass also assists you with knowing the L-Arginine API Price utilized in the formulation of products. L-Arginine API Price is not always fixed or binding as the L-Arginine Price is obtained through a variety of data sources. The L-Arginine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

L-Arginine

Synonyms

74-79-3, L-(+)-arginine, L(+)-arginine, L-arg, (s)-2-amino-5-guanidinopentanoic acid, H-arg-oh

Cas Number

74-79-3

Unique Ingredient Identifier (UNII)

94ZLA3W45F

About L-Arginine

An essential amino acid that is physiologically active in the L-form.

arg Manufacturers

A arg manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of arg, including repackagers and relabelers. The FDA regulates arg manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. arg API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of arg manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

arg Suppliers

A arg supplier is an individual or a company that provides arg active pharmaceutical ingredient (API) or arg finished formulations upon request. The arg suppliers may include arg API manufacturers, exporters, distributors and traders.

click here to find a list of arg suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

arg USDMF

A arg DMF (Drug Master File) is a document detailing the whole manufacturing process of arg active pharmaceutical ingredient (API) in detail. Different forms of arg DMFs exist exist since differing nations have different regulations, such as arg USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A arg DMF submitted to regulatory agencies in the US is known as a USDMF. arg USDMF includes data on arg's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The arg USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of arg suppliers with USDMF on PharmaCompass.

arg JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The arg Drug Master File in Japan (arg JDMF) empowers arg API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the arg JDMF during the approval evaluation for pharmaceutical products. At the time of arg JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of arg suppliers with JDMF on PharmaCompass.

arg CEP

A arg CEP of the European Pharmacopoeia monograph is often referred to as a arg Certificate of Suitability (COS). The purpose of a arg CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of arg EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of arg to their clients by showing that a arg CEP has been issued for it. The manufacturer submits a arg CEP (COS) as part of the market authorization procedure, and it takes on the role of a arg CEP holder for the record. Additionally, the data presented in the arg CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the arg DMF.

A arg CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. arg CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of arg suppliers with CEP (COS) on PharmaCompass.

arg NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing arg as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for arg API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture arg as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain arg and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a arg NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of arg suppliers with NDC on PharmaCompass.

arg GMP

arg Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of arg GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right arg GMP manufacturer or arg GMP API supplier for your needs.

arg CoA

A arg CoA (Certificate of Analysis) is a formal document that attests to arg's compliance with arg specifications and serves as a tool for batch-level quality control.

arg CoA mostly includes findings from lab analyses of a specific batch. For each arg CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

arg may be tested according to a variety of international standards, such as European Pharmacopoeia (arg EP), arg JP (Japanese Pharmacopeia) and the US Pharmacopoeia (arg USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty